Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Nuclear Medicine Technology|August 30, 2022
Posttreatment Exposure Rates for 90Y-Microsphere Patients: A Comparison of ProductsSteven Blum, Eugenio Silvestrini, Jonathan Weinstein, et al.Journal of Medical Economics|April 20, 2011
Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysisAndrew P Yu, Hongbo Yang, Eric Q Wu, et al.Journal of Medical Economics|October 1, 2010
Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective studyAndrew P Yu, Jipan Xie, Arielle Bensimon, et al.The Annals of Pharmacotherapy|March 19, 2011
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorderEric Q Wu, Andrew P Yu, Veronique Lauzon, et al.Journal of Medical Economics|June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costsAndrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.Brachytherapy|August 31, 2024
Dosimetric evaluation of adaptive planning for five-fraction gynecologic template-based interstitial brachytherapySteven Blum, Jessica R Miller, Kristin A Bradley, et al.ACS Synthetic Biology|November 22, 2019
Organism Engineering for the Bioproduction of the Triaminotrinitrobenzene (TATB) Precursor Phloroglucinol (PG)Adam Meyer, Ishtiaq Saaem, Adam Silverman, et al.Pageof 1